Care Outcomes Among Black or African American Persons with Diagnosed HIV in Rural, Urban, and Metropolitan Statistical Areas — 42 U.S. Jurisdictions, 2018
Weekly / February 19, 2021 / 70(7);229–235
Shacara Johnson Lyons, MSPH1; André F. Dailey, MSPH1; Chenchen Yu, MPH1,2; Anna Satcher Johnson, MPH1 (View author affiliations)View suggested citation
What is already known about this topic?
Disparities in HIV care outcomes exist for Black persons with diagnosed human immunodeficiency virus (HIV) infection, and access to care and treatment services varies by residence area.
What is added by this report?
During 2018, rural Black persons received a higher percentage of late-stage HIV diagnosis (25.2%) than did those in urban (21.9%) and metropolitan areas (19.0%). Linkage to care within 1 month of diagnosis was similar across geographic areas; however, viral suppression within 6 months of diagnosis was highest in metropolitan areas (63.8%).
What are the implications for public health practice?
Early diagnosis and prompt treatment of Black persons with HIV infection, especially in rural areas, are necessary to reduce disparities in HIV care outcomes.
Views equals page views plus PDF downloads
During 2018, Black or African American (Black) persons accounted for 43% of all diagnoses of human immunodeficiency virus (HIV) infection in the United States (1). Among Black persons with diagnosed HIV infection in 41 states and the District of Columbia for whom complete laboratory reporting* was available, the percentages of Black persons linked to care within 1 month of diagnosis (77.1%) and with viral suppression within 6 months of diagnosis (62.9%) during 2018 were lower than the Ending the HIV Epidemic initiative objectives of 95% for linkage to care and viral suppression goals (2). Access to HIV-related care and treatment services varies by residence area (3–5). Identifying urban-rural differences in HIV care outcomes is crucial for addressing HIV-related disparities among Black persons with HIV infection. CDC used National HIV Surveillance System† (NHSS) data to describe HIV care outcomes among Black persons with diagnosed HIV infection during 2018 by population area of residence§ (area). During 2018, Black persons in rural areas received a higher percentage of late-stage diagnoses (25.2%) than did those in urban (21.9%) and metropolitan (19.0%) areas. Linkage to care within 1 month of diagnosis was similar across all areas, whereas viral suppression within 6 months of diagnosis was highest in metropolitan areas (63.8%). The Ending the HIV Epidemic initiative supports scalable, coordinated, and innovative efforts to increase HIV diagnosis, treatment, and prevention among populations disproportionately affected by or who are at higher risk for HIV infection (6), especially during syndemics (e.g. with coronavirus disease 2019).
CDC analyzed data reported to NHSS for Black persons aged ≥13 years who received a diagnosis of HIV during 2018 in 41 states¶ and the District of Columbia, jurisdictions in which laboratory reporting was complete as of December 31, 2019. Stage of disease** at diagnosis was classified using the 2014 surveillance case definition for HIV infection based on age-specific CD4 counts or percentages of total lymphocytes (2,7). Linkage to care within 1 month of diagnosis was measured by documentation of one or more CD4 counts or percentage of viral load test results within 1 month after diagnosis. Viral suppression within 6 months of HIV diagnosis was defined as a viral load of <200 HIV RNA copies/mL within 6 months of HIV diagnosis. Data were statistically adjusted by using multiple imputation techniques to account for missing HIV transmission categories (8). Analyses were conducted using SAS (version 9.4; SAS Institute).
Among 14,502 Black persons who received a diagnosis of HIV infection during 2018, a total of 897 (6.2%) lived in a rural area, 1,920 (13.2%) lived in an urban area, and 11,685 (80.6%) lived in a metropolitan area. The percentage of Black persons who received a late (stage 3, acquired immunodeficiency syndrome) diagnosis of HIV infection was highest in rural areas (25.2%), followed by urban and metropolitan areas (21.9% and 19.0%, respectively) (Table 1) (Supplementary Figure, https://stacks.cdc.gov/view/cdc/102576). Females were more likely than were males to receive a late-stage diagnosis. The highest percentage of late-stage diagnoses was among females in rural areas (females, rural: 31.4%, urban: 23.1%, metropolitan: 20.6%; males, rural: 23.0%, urban: 21.5%, metropolitan: 18.6%). The highest percentages of late-stage diagnoses occurred among persons aged 45–54 years in both rural and metropolitan areas (47.9% and 31.4%, respectively); in urban areas, the percentage of late-stage diagnoses was highest among persons aged ≥55 years (43.1%). By transmission category, the percentage of late-stage diagnoses was highest in all areas among males whose infection was attributed to heterosexual contact (rural: 37.2%, urban: 32.5%, metropolitan: 28.3%).
Overall, the percentage of Black persons with HIV infection diagnosed during 2018 who were linked to care within 1 month of diagnosis was 76.7% in rural areas, 77.0% in urban areas, and 77.2% in metropolitan areas (Table 2) (Supplementary Figure, https://stacks.cdc.gov/view/cdc/102576). Males were less likely than were females to be linked to care, regardless of area (males, rural: 75.2%, urban: 75.0%, metropolitan: 76.4%; females, rural: 81.8%, urban: 82.7%, metropolitan: 79.5%). Males aged 45–54 years in rural and urban areas with infection attributed to heterosexual contact (rural: 69.9%, urban: 67.1%) and males aged 13–24 years in metropolitan areas with infection attributed to heterosexual contact (62.3%) accounted for the lowest percentage of being linked to care compared with persons with other modes of transmission in those areas.
Overall, the percentage of Black persons aged ≥13 years in rural areas with HIV diagnosed during 2018 who had <200 copies of viral RNA per mL (viral suppression) within 6 months of diagnosis was 59.6% in rural areas, 59.7% in urban areas, and 63.8% in metropolitan areas (Table 3) (Supplementary Figure, https://stacks.cdc.gov/view/cdc/102576). The percentage of males with viral suppression within 6 months of diagnosis was lower than the percentage among females, regardless of area (males, rural: 58.0%, urban: 57.8%, metropolitan: 62.4%; females, rural: 64.0%, urban: 65.1%, metropolitan: 68.1%). By age group and area, the lowest percentage of viral suppression within 6 months of diagnosis was among persons aged 45–54 years in rural and urban areas (52.1% and 56.4%, respectively) and persons aged 13–34 years in metropolitan areas (62.6%). In rural and urban areas, the lowest percentage of viral suppression within 6 months of diagnosis was among males aged 45–54 years with infection attributed to male-to-male sexual contact and to heterosexual contact (44.2% and 42.5%, respectively). In metropolitan areas, the lowest percentage of viral suppression within 6 months of diagnosis was among males aged 13–24 years with infection attributed to heterosexual contact (51.7%) and males aged 25–34 years with infection attributed to injection drug use (IDU) (45.0%).
During 2018, one in four (25.2%) diagnosed HIV infections among Black persons in rural areas was a late-stage diagnosis, a percentage that was higher than that among Black persons in urban (21.9%) and metropolitan (19.0%) areas. The percentages of patients linked to care within 1 month of diagnosis were similar in all areas, whereas the percentages of persons with viral suppression within 6 months of diagnosis were lower in rural (59.6%) and urban (59.7%) areas than in metropolitan areas (63.8%). In all areas, the percentages of persons who were linked to care within 1 month of diagnosis and who had viral suppression within 6 months of diagnosis were substantially below the Ending the HIV Epidemic initiative targets of 95% (9). These findings likely underscore known differences in health-related behaviors, physical and sociocultural environments, and access to and use of health care systems among Black urban and rural HIV populations (3,4).
By transmission category, the highest percentages of late-stage diagnoses in all areas were among males with infection attributed to heterosexual contact. The lowest levels of linkage to care within 1 month of diagnosis were among males in rural areas with infection attributed to both male-to-male sexual contact and IDU, and males in urban areas with infection attributed to IDU. Viral suppression within 6 months of diagnosis was least common in all areas among males aged ≥13 years with infection attributed to IDU. Broader implementation of routine HIV testing is needed to identify persons with undiagnosed infections and to initiate early treatment, particularly among older persons. Interventions that support patient retention and re-engagement in HIV care are necessary to improve care outcomes and reduce HIV transmission. Locally tailored strategies among Black persons who inject drugs and sexually active adults at higher risk for HIV infection should be implemented for effective prevention in both urban and rural areas.
The findings in this report are subject to at least three limitations. First, analyses were limited to the 42 jurisdictions with complete laboratory reporting; these jurisdictions might not be representative of all Black persons living with diagnosed HIV infection in the United States. Second, CD4 and viral load test results reported to HIV surveillance programs were used for determining stage of disease and monitoring linkage to care and viral suppression; CD4 and viral load laboratory tests might not have been obtained at all care visits. Not having these tests performed among patients in care or unreported to surveillance systems limits the ability to monitor care outcomes. Finally, comparisons of numbers and percentages by area, sex, age group, and transmission category should be made cautiously because population subgroups vary in size and some have small numbers. Reported numbers ≤12 and their accompanying percentages are not discussed.
Early HIV diagnosis and treatment among Black persons with HIV infection are necessary to reduce disparities and achieve national prevention goals. For equitable health to be achieved for Black persons in all geographic areas, culturally appropriate and stigma-free sexual health care is needed, particularly among those who live in rural communities. Although 80% of Black persons with diagnosed HIV live in metropolitan areas, identifying geographic disparities is important to ensure HIV-related health equity. Disparities in care outcomes should be addressed and interventions prioritized that address social determinants of health.††
Corresponding author: Shacara Johnson Lyons, SJohnsonLyons@cdc.gov, 404-718-1149.
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
* CDC has established three criteria for complete laboratory reporting: 1) the jurisdiction’s laws or regulations require reporting of all CD4 and viral load results to the state or local health department; 2) laboratories that perform HIV-related testing for the area must have reported a minimum of 95% of HIV-related test results to the state or local health department; and 3) by December 31, 2019, the jurisdiction had reported to CDC ≥95% of all CD4 and viral load results received during January 2017–September 2019. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
† The National HIV Surveillance System is the primary source for monitoring HIV trends in the United States. Through that system, CDC funds and assists state and local health departments for collecting data regarding HIV infection cases. Health departments provide deidentified data to CDC.
§ Area of residence at HIV diagnosis was categorized as rural (<50,000 population), urban (50,000–499,999 population), or metropolitan (≥500,000 population) according to the Office of Management and Budget 2010 standards for delineating metropolitan and micropolitan statistical areas (http://www.federalregister.gov/documents/201006/28/2010-15605/2010-standards-for-delineating-metropolitan-and-micropolitan-statistical-areasexternal icon).
¶ Alabama, Alaska, California, Colorado, Delaware, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming.
** Disease stages are defined as follows: stage zero, the first positive HIV test result ≤6 months after a negative HIV test result and remaining at Stage zero until 6 months after the first positive test result; stage 1, a CD4 count of ≥500 cells/µL or CD4 percentage of ≥26; stage 2, a CD4 count of 200–499 cells/µL or CD4 percentage of 14–25; stage 3 (acquired immunodeficiency syndrome [AIDS]), a CD4 count of <200 cells/µL or CD4 percentage of <14 or documentation of an AIDS-defining condition. Stages of disease are further classified as stage zero; stages 1–2: early-stage diagnosis; and stage 3 [AIDS]: late-stage diagnosis.
- CDC. Diagnoses of HIV infection in the United States and dependent areas, 2018. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-31/index.html
- CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2018. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplemental-report-vol-25-2.pdfpdf icon
- Nelson JA, Kinder A, Johnson AS, et al. Differences in selected HIV care continuum outcomes among people residing in rural, urban, and metropolitan areas—28 US jurisdictions. J Rural Health 2018;34:63–70. https://doi.org/10.1111/jrh.12208external icon PMID:27620836external icon
- Nwangwu-Ike N, Saduvala N, Watson M, Panneer N, Oster AM. HIV diagnoses and viral suppression among US women in rural and nonrural areas, 2010–2017. J Rural Health 2020;36:217–23. https://doi.org/10.1111/jrh.12384external icon PMID:31233645external icon
- Office of National AIDS Policy. National HIV/AIDS strategy for the United States: updated to 2020. Washington, DC: Office of National AIDS Policy; 2015. https://www.hiv.gov/sites/default/files/nhas-2020-action-plan.pdfpdf iconexternal icon
- Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA 2019;321:844–5. https://doi.org/10.1001/jama.2019.1343external icon PMID:30730529external icon
- CDC. Revised surveillance case definition for HIV infection—United States, 2014. MMWR Recomm Rep 2014;63(No. RR-3):1–10.https://www.cdc.gov/mmwr/pdf/rr/rr6303.pdfpdf icon PMID:24717910external icon
- Harrison KM, Kajese T, Hall HI, Song R. Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep 2008;123:618–27. https://doi.org/10.1177/003335490812300512external icon PMID:18828417external icon
- US Department of Health and Human Services. America’s HIV epidemic analysis dashboard (AHEAD). Washington, DC: US Department of Health and Human Services; 2020. https://ahead.hiv.gov/external icon
Suggested citation for this article: Lyons SJ, Dailey AF, Yu C, Johnson AS. Care Outcomes Among Black or African American Persons with Diagnosed HIV in Rural, Urban, and Metropolitan Statistical Areas — 42 U.S. Jurisdictions, 2018. MMWR Morb Mortal Wkly Rep 2021;70:229–235. DOI: http://dx.doi.org/10.15585/mmwr.mm7007a1external icon.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to firstname.lastname@example.org.